High-dose versus low-dose cyclophosphamide in combination with G-CSF for peripheral blood progenitor cell mobilization. - Wikidata - awgldk - TriplyDB

High-dose versus low-dose cyclophosphamide in combination with G-CSF for peripheral blood progenitor cell mobilization.

High-dose versus low-dose cyclophosphamide in combination with G-CSF for peripheral blood progenitor cell mobilization.

http://www.wikidata.org/entity/Q33369286

about

Stem cell mobilization in HIV seropositive patients with lymphoma.Current status of stem cell mobilization.

P2860

Q37273199-760B2D2A-A468-4FD0-AEF5-5E503E35D0CF Q37773388-0346BAF4-AEA9-4BCF-A4D3-75431891EEAD

P2860

High-dose versus low-dose cyclophosphamide in combination with G-CSF for peripheral blood progenitor cell mobilization.

http://www.wikidata.org/entity/Q33369286

description

2005 nî lūn-bûn

@nan

2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

High-dose versus low-dose cycl ...... progenitor cell mobilization.

@ast

High-dose versus low-dose cycl ...... progenitor cell mobilization.

@en

type

label

High-dose versus low-dose cycl ...... progenitor cell mobilization.

@ast

High-dose versus low-dose cycl ...... progenitor cell mobilization.

@en

prefLabel

High-dose versus low-dose cycl ...... progenitor cell mobilization.

@ast

High-dose versus low-dose cycl ...... progenitor cell mobilization.

@en

P1433

Q33369286-C32A5A50-84E6-42C1-9CF9-F07AFE133B30

P1476

Q33369286-C41915CE-FA0C-409E-95A0-E933E5E27738

P2093

Q33369286-15DAA265-95D6-48BF-8163-21D459947DC7

Q33369286-235CF755-6A7B-4BA5-9BF2-B222FF7BA4C3

Q33369286-2F410E83-FB7C-4BD5-B19F-BAEA50D9C168

Q33369286-459A1709-BBEB-4630-9E0C-C14E81964FD0

Q33369286-6567176A-10FC-41AD-B459-3711F5A4DD6B

Q33369286-6685CE51-A3AC-411C-8A61-3B14B4D7185A

Q33369286-77A872D4-7CD5-4C63-A935-27F6856878E3

Q33369286-7A8D4796-93B3-4EB6-A731-C22F26467B4D

Q33369286-7AD0830B-14BB-4D51-BC36-3F77EBBD9E3E

Q33369286-9939FF42-8977-4F7F-AE06-A75187C0B82A

P2860

Q33369286-29A65610-7373-499E-A103-414D18D34851

Q33369286-41E9B3AB-27E9-4EB8-819B-D3F79CE58BE5

Q33369286-5F64AC04-4B97-41F8-91C6-37EF4506103C

Q33369286-65F58A05-4DF7-49D3-A985-D20DCF10063C

Q33369286-7EDA485E-EAD9-4A7D-A69E-335E00400078

Q33369286-818CC6E8-92ED-4902-AD81-295970EBA788

Q33369286-84D1865B-20AD-4722-8AA2-B8D0927B7955

Q33369286-89E3F064-DC12-4B48-B3CC-EFBA8E2E8218

Q33369286-9E2833A7-D151-40EC-BB0E-FD71DA8596B2

Q33369286-9E5460C6-C645-4EAD-B228-EBE61329345E

P304

Q33369286-6FEDF224-C68E-44D4-B873-413470248B49

P31

Q33369286-D12799A0-1141-4B62-A2BB-6A9A13B7A58C

P356

Q33369286-78DB9C2C-BAC8-4808-8AF4-BE472BD2E120

P433

Q33369286-A9EF9C9B-1DC3-434F-8880-0C6AD5E3CDED

P478

Q33369286-1E5D8DA7-E23D-4CDF-ACE4-064AAAFD474D

P577

Q33369286-275AC1A6-3085-4DBA-B98A-EA91DB5B114B

P5875

Q33369286-2CD51253-3413-488E-816A-40B4C1F44DA4

P698

Q33369286-91C32E61-3087-45C2-828F-F52FA491ABF9

P932

Q33369286-F60AB9BD-9425-4E75-85CB-E39F930E0CA0

P356

KJIM.2005.20.3.224

P1433

The Korean journal of internal medicine

P1476

High-dose versus low-dose cycl ...... progenitor cell mobilization.

@en

P2093

Byoung Kook Kim

http://www.w3.org/2001/XMLSchema#string

Chu Myung Seong

http://www.w3.org/2001/XMLSchema#string

Chul Soo Kim

http://www.w3.org/2001/XMLSchema#string

Chul Won Jung

http://www.w3.org/2001/XMLSchema#string

Eun Kyung Cho

http://www.w3.org/2001/XMLSchema#string

Hugh Chul Kim

http://www.w3.org/2001/XMLSchema#string

Jae Hoon Lee

http://www.w3.org/2001/XMLSchema#string

Jin Seok Ahn

http://www.w3.org/2001/XMLSchema#string

Jong-Seok Lee

http://www.w3.org/2001/XMLSchema#string

Jung Ae Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy.

Peripheral blood progenitor cell transplantation.

Prospective randomized clinical trial comparing high-dose ifosfamide + GM-CSF vs high-dose cyclophosphamide + GM-CSF for blood progenitor cell mobilization.

Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF.

Peripheral blood progenitor cells for marrow reconstitution: mobilization and collection strategies.

The biology and clinical uses of blood stem cells.

Analysis of human hematopoietic stem cell populations.

Recent advances in flow cytometry: application to the diagnosis of hematologic malignancy.

Mobilization of peripheral blood stem cells with high-dose cyclophosphamide or the DHAP regimen plus G-CSF in non-Hodgkin's lymphoma.

Results of high-dose therapy and autologous bone marrow/stem cell transplantation during remission in poor-risk intermediate- and high-grade lymphoma: international index high and high-intermediate risk group.

P304

224-231

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3904/KJIM.2005.20.3.224

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2005-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7472380

http://www.w3.org/2001/XMLSchema#string

P698

16295781

http://www.w3.org/2001/XMLSchema#string

P932

3891157

http://www.w3.org/2001/XMLSchema#string